The pro115Gln polymorphism within the PPAR γ2 gene has no epidemiological impact on morbid obesity

Experimental and Clinical Endocrinology and Diabetes

Volumn 110, Issue 5, 2002, Pages 230-234

  Hamer, O W ^a   Forstner, D ^a   Ottinger, I ^a   Ristow, M ^a   Bollheimer, L C ^a   Scholmerich J ^a   Palitzsch, K D ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Epidemiology; Obesity; Peroxisome proliferator activated receptor 2; Polymorphism; Pro115Gln

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; UNCLASSIFIED DRUG; C PEPTIDE; CELL RECEPTOR; CHOLESTEROL; GLUTAMINE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PROLINE; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA DETERMINATION; EPIDEMIOLOGICAL DATA; FEMALE; GENE FUNCTION; GENETIC POLYMORPHISM; GERMANY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORBID OBESITY; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; BLOOD; BLOOD PRESSURE; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-PEPTIDE; CHOLESTEROL; GERMANY; GLUTAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; INSULIN; LIPOPROTEINS, HDL CHOLESTEROL; MIDDLE AGE; OBESITY, MORBID; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLINE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; CHOLESTEROL, HDL; HUMANS; MIDDLE AGED;

EID: 0036024171     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33072     Document Type: Article

References (32)

1. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
2. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients
3. PPARgamma, the ultimate thrifty gene
4. Genetics of obesity in humans: Current issues
5. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
6. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes
7. Thiazolidinediones: A new class of antidiabetic drugs
8. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
9. Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity
10. PPARgamma3 mRNA: A distinct PPARgamma mRNA subtype transcribed from an independent promoter
11. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping
12. Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects
13. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma
14. Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes
15. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
16. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism
17. Evolution of the nuclear receptor gene superfamily
18. Genetic and environmental factors in relative body weight and human adiposity
19. Effect of troglitazone on body fat distribution in type 2 diabetic patients
20. Die praevalenz des diabetes mellitus wird in Deutschland deutlich unterschätzt - Eine bundesweite epidemiologische studie auf der basis einer HbA1c-analyse
21. Etiology of massive obesity: Role of genetic factors
22. Learning to use troglitazone
23. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
24. Troglitazone: Antihyperglycemic activity and potential role in the treatment of type 2 diabetes
25. Role of the peroxisome proliferatoractivated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
26. The genetics of obesity
27. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
28. Adipogenesis and obesity: Rounding out the big picture
29. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid- activated transcription factor
30. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids
31. Negative regulation of peroxisome proliferatoractivated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha
32. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: Alternative promoter use and different splicing yield two mPPAR gamma isoforms